A recent study reported unique neighborhood compositions surrounding NK cells in HER2− versus HER+ BC, where NK cells from HER2− tumors were more frequently found proximal to tumor cells, whereas those from HER2+ tumors were more frequently proximal to CD3+ T‐cells [47]. This evidence concerns the gene ERBB2 and breast cancer.